Thoughts on Longaeva?
Notice they've been hiring a ton past few months (one of my former colleagues joined them) - curious if anyone has any thoughts on them? Basic spin-out out of a MM like Ashler, etc.? Worth trying to get an interview with them?
Notice they've been hiring a ton past few months (one of my former colleagues joined them) - curious if anyone has any thoughts on them? Basic spin-out out of a MM like Ashler, etc.? Worth trying to get an interview with them?
| +33 | Do Quantamental roles really exist? | 13 | 4h |
| +18 | Worth Joining a Small Hedge Fund? | 12 | 6h |
| +15 | Average single manager slope | 5 | 4d |
| +15 | L/S Equity Career London | 8 | 17h |
| +10 | Hedge Fund (Fundamental Long Short Equity) Compensation in Singapore Hong Kong | 2 | 1d |
| +9 | Bad PM | 5 | 2d |
| +8 | Yes, this question again… | 3 | 9h |
| +6 | P72 final round resubmitting case study | 1 | 13h |
| +5 | X | 6 | 3d |
Career Resources
Bump
First off Ashler is not a spin-out… it’s one of Citadels 3 equities businesses (surveyor, ashler, and citadel global equities). The spinouts are the Woodlines, Holocenes, Candlesticks of the world.
From what I’ve gathered it is somewhere in between how Millenium and Citadel do it. ie it appears to be an equity business of Balyasny but it functions pretty independently like how the Millenium seeded funds operate.
Peter Goodwin is super super sharp though so in my opinion definitely a great opportunity to work for him.
Anyone know if they have started trading / how they have managed thru this period of vol?
bump
Heard they weren't fully deployed so impact wasn't terrible in the grand scheme.
Good reputation overall, but has been very slow to ramp/hire, as with many other new launches recently across the street in healthcare.
Risk model is going to largely be the same as baly, irrespective of what is suggested.
From a mentorship standpoint, Peter unlikely to be personally involved in anything but healthcare book (he's hired more junior talent there) as a result, and his expertise is more in services/medtech, not therapeutics.
At the end of the day, a pod is a pod; they're not trying to do anything radically different.
They are not just healthcare. Supposed to mirror the corbets structure with consumer / industrials / tmt teams too?
That's right but Peter is directly managing the healthcare book, and hired more senior sub-PMs for the other sectors, as he did at Point72.
Peter not getting more flexible risk than rest of Baly?
Don't know about Peter specifically, but would say that none of these larger build outs really are that different, maybe on the margin, more so because of sunk cost than anything else; it's just that when you run diversified in sector and with more sleeves; correlation, vol, and therefore overall drawdown risk is inherently lower. Exactly why you never see the MMs down more than a percent
i was told you could run lower idio with him
Hired a couple really sharp juniors in my network recently...
I know someone there as well. Place is very well run. Some difference in quality between sectors but overall seems like a machine.
Also, mentioning Ashler was not particularly smart; now it's obvious you're from there, doing healthcare, and have been there for a while, which narrows down identity to 3-4 people
Quo voluptatibus expedita quia cumque ut dolorem ut. Deleniti delectus sunt numquam aliquam. Reiciendis ad tempore harum quasi laborum quia ratione.
Quaerat quod ut magnam illum molestiae et sit. Assumenda inventore id ab recusandae. Mollitia unde iusto excepturi officiis.
Sed necessitatibus velit nemo iste exercitationem. Ab asperiores perspiciatis laborum minima.
Nostrum eum ad non harum. Et atque itaque odit error voluptatibus sit voluptas.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...